Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-25-006517
Filing Date
2025-01-17
Accepted
2025-01-17 11:30:03
Documents
2
Period of Report
2025-01-17

Document Format Files

Seq Description Document Type Size
1 6-K press_release_jan_17_202.htm 6-K 22591
2 EX-99.1 ipa-ex99_1.htm EX-99.1 15977
  Complete submission text file 0000950170-25-006517.txt   39599
Mailing Address 3204-4464 MARKHAM ST. VICTORIA A1 V8Z 7X8
Business Address 3204-4464 MARKHAM ST. VICTORIA A1 V8Z 7X8 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 6-K | Act: 34 | File No.: 001-39530 | Film No.: 25537621
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)